Category:

Release – Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Posted on by aweinsoff@channelchek.com

Research News and Market Data on ELDN

July 30, 2025

PDF Version

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the company will host a conference call and webcast on Wednesday, August 6, 2025 at 4:30 p.m. ET to discuss updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for the prevention of rejection in subjects undergoing kidney transplantation. These data, from approximately 30 kidney transplant recipients, are being presented at the World Transplant Congress (WTC) in San Francisco, CA on August 6, 2025.

To join the conference call, please dial 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. The conference ID is 34575. Registration for the live webcast can be found here and available on the “Events” section of Eledon’s website at www.eledon.com. The webcast will be archived on the website following the completion of the call.

About Eledon Pharmaceuticals and tegoprubart

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40 Ligand biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California. For more information, please visit the Company’s website at www.eledon.com.

Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter

Investor Contact:

Stephen Jasper
Gilmartin Group
(858) 525 2047
stephen@gilmartinir.com

Media Contact:

Jenna Urban
CG Life
(212) 253 8881
jurban@cglife.com

Source: Eledon Pharmaceuticals

Primary Logo

Source: Eledon Pharmaceuticals, Inc.

Release – MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders

Posted on by aweinsoff@channelchek.com

Research News and Market Data MGROF

Jul 30, 2025 | News Releases

SASKATOON, Saskatchewan, Canada, July 30, 2025 – MustGrow Biologics Corp. (TSXV: MGRO; OTC: MGROF; FRA: 0C0) (the “Company” or “MustGrow“), is pleased to announce the following: (i) a non-brokered private placement of up to 4,285,715 units of the Company (each, a “Unit“) at a price of $0.70 per Unit for gross proceeds of up to $3,000,000 (the “LIFE Offering“); (ii) the proposed repricing of outstanding share purchase warrants issued pursuant to its January 16, 2025 private placement (the “Warrant Repricing“); and (iii) its intention to offer shares for debt settlement to all holders of unsecured convertible debentures issued pursuant to its January 16, 2025 private placement (the “Shares for Debenture Debt Settlement“).

LIFE Offering

Each Unit will consist of (i) one common share of the Company (a “Share“); and (ii) one common share purchase warrant (a “Warrant“). Each whole Warrant will be exercisable for a period of 60 months from the Closing Date (defined below) and will entitle the holder thereof to purchase one additional Share (a “Warrant Share“) at an exercise price of $0.90 per Warrant Share.

The Company intends to use the net proceeds raised from the LIFE Offering for inventory production for its mustard-derived organic biofertility product TerraSanteTM, inventory for agricultural products to sell via its Canadian distribution platform NexusBioAg, and working capital and general corporate purposes.

Subject to the rules and policies of the TSX Venture Exchange (the “TSXV“), the securities issuable from the sale of Units to Canadian resident subscribers will not be subject to a hold period under applicable Canadian securities laws. Insiders and certain consultants that participate in the LIFE Offering would be subject to a four-month hold period pursuant to applicable policies of the TSXV.

There is an offering document related to the LIFE Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.MustGrow.ca. Prospective investors should read this offering document before making an investment decision.

It is expected that closing of the LIFE Offering will take place on or about August 21, 2025 or such other date(s) as may be determined by the Company (the “Closing Date“). Closing of the LIFE Offering is subject to certain conditions including, but not limited to, receipt of all necessary approvals, including the approval of the TSXV.

The Units sold pursuant to the LIFE Offering will be offered in Canada pursuant to the listed issuer financing exemption from the prospectus requirement available under Part 5A of National Instrument 45-106 – Prospectus Exemptions as modified by Coordinated Blanket Order 45-935 Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “LIFE Exemption“), in the United States pursuant to available exemptions from the registration requirements of the United States Securities Act of 1933 (the “1933 Act”), as amended, and in certain other jurisdictions outside of Canada and the United States provided that no prospectus filing or comparable obligation arises in such other jurisdiction.

As consideration for services, certain eligible finders may receive (i) an aggregate cash fee equal up to 6.0% of the gross proceeds of the LIFE Offering from investors introduced to the Company by the finder; and (ii) non-transferable common share purchase warrants (the “Finder’s Warrants“) representing up to 6.0% of the aggregate number of Shares forming part of the Units issued to investors introduced to the Company by the finder. Each Finder’s Warrant will entitle its holder to purchase one Share (a “Finder Warrant Share“) at a price of $0.90 per Share for a 60-month period. The Finder Warrants and any Finder Warrant Shares issuable upon exercise thereof will be subject to a statutory hold period expiring four months and one day following the date of issue in accordance with applicable Canada securities laws.

Warrant Repricing

The Company intends to reprice an aggregate of 1,721,610 outstanding common share purchase warrants (the “Warrants“) issued pursuant to its January 16, 2025 private placement. The Warrants have an exercise price of $1.90 and an expiry date of January 16, 2030.

Provided the Company receives Warrant Amendment Approval (defined below), the Warrants will be deemed to be amended to adjust their exercise price to $0.90 per Share (the “Amended Warrants“). The Amended Warrants will also be amended to include an acceleration provision whereby, if for any ten (10) consecutive trading days (the “Premium Trading Days“) following the completion of the Warrant Repricing the closing price of the Company’s Shares exceeds $1.08, the Amended Warrants’ expiry date will be accelerated such that holders will have thirty (30) calendar days to exercise the Amended Warrants (if they have not first expired in the normal course) (the “Acceleration Clause“). The activation of the Acceleration Clause will be announced by press release and the 30-day period will commence seven (7) days after the last Premium Trading Day.

The Warrant Repricing is subject to the prior consent of all Warrantholders and the approval of the TSXV (“Warrant Amendment Approval“). The Company intends to issue an updating news release upon receipt, if any, of Warrant Amendment Approval.

Shares for Debenture Debt Settlement

The Company intends to offer a shares for debt settlement to all holders of unsecured convertible debentures issued pursuant to its January 16, 2025 private placement (the “Debentures“), to settle the outstanding principal amount owing under the Debentures, in the aggregate amount of up to $2,585,000 in consideration for: (i) the issuance of up to an aggregate of up to approximately 3,692,860 Shares (the “Settlement Shares“) at a deemed price of $0.70 per Settlement Share, and (ii) a cash payment of all accrued and unpaid interest up to the date of issuance of the Settlement Shares.

The Settlement Shares will be subject to a statutory hold period expiring four months and one day from the date of issuance, in accordance with applicable securities laws and TSXV policies.

Closing of the Shares for Debenture Debt Settlement is subject to the execution of definitive settlement documentation with any accepting holders of Debentures and the approval of the TSXV. The Company intends to issue an updating news release upon closing of the Shares for Debenture Debt Settlement.

MI 61-101 Compliance

It is anticipated that: (i) insiders of the Company may participate in the LIFE Offering, and any Units issued to insiders will be subject to a four month hold period pursuant to applicable policies of the TSXV; (ii) insiders of the Company may participate in the Warrant Repricing (subject to the rules and policies of the TSXV); and (iii) insiders of the Company may participate in the Shares for Debenture Debt Settlement, and any Settlement Shares issued to insiders will be subject to a four month hold period pursuant to applicable policies of the TSXV.

The issuance of Units to any insiders, the participation of any insiders in the Warrant Repricing, and the issuance of Settlement Shares to any insiders will be considered a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61- 101“). In respect of any such insider participation, the Company expects to rely on exemptions from the formal valuation requirements of MI 61-101 pursuant to section 5.5(a) and the minority shareholder approval requirements of MI 61-101 pursuant to section 5.7(1)(a), as the fair market value of the transaction, insofar as it involves interested parties, does not exceed 25% of the Company’s market capitalization.

Not an Offer to Sell or Solicitation in the US

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the 1933 Act, or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

About MustGrow

MustGrow Biologics Corp. is a fully-integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company’s proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, MustGrow offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants and foliar products. These products are synergistically distributed alongside MustGrow’s wholly-owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, MustGrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize MustGrow’s wholly-owned proprietary products and technologies. The Company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio of approximately 112 patents that are currently issued and pending, and the sales and distribution of its proprietary and third-party product lines through NexusBioAg. MustGrow is a publicly traded company (TSXV-MGRO) and has approximately 52.4 million common shares issued and outstanding and 59.4 million shares fully diluted. For further details, please visit www.mustgrow.ca.

Contact Information

Corey Giasson Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca

MustGrow Forward-Looking Statements

Certain statements included in this news release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.

Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Forward-looking statements in this press release, including statements about: certain proposed financing transactions and the intended use of proceeds, and are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include: risks relating to the Company’s ability to complete the proposed financing transactions on the terms and timeline contemplated herein, or at all, including the receipt of final approvals from the TSXV and satisfaction of other closing conditions, and those risks described in more detail in MustGrow’s Annual Information Form for the year ended December 31, 2024 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.

Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.

© 2025 MustGrow Biologics Corp. All rights reserved.

Release – Nicola Mining Commences 10,000 Tonne Bulk Sample At High Grade Dominion Creek Mineral Project

Posted on by aweinsoff@channelchek.com

Research News and Market Data on HUSIF

July 30, 2025

News Releases

VANCOUVER, B.C., July 30, 2025 – Nicola Mining Inc. (TSX.V: NIM)(FSE: HLI) (OTCQB: HUSIF), (the “Company” or “Nicola”) is pleased to announce that it has commenced work on its 10,000 bulk sample[1] at its Dominion Creek Mineral Project (“Dominion”), a high grade gold and silver project, of which Nicola owns a 75% economic interest. 

Nicola has already purchased in cash and installed a 14-man camp, which includes fully furnished rooms and all required facilities.  A bridge has been installed, equipment mobilized, and contractors are at site.  Roadwork, which includes improvements to the bulk sample site, has commenced and is expected to be completed prior to August 10th, after which extraction can commence.

The Company announced on March 6, 2025 that it has been issued a draft permit by the British Columbia Ministry of Mining and Critical Minerals to extract 10,000 tonnes of gold and silver ore at Dominion, which is located 43 kilometers northeast of the Town of Wells and approximately 110 kilometers east-southeast of Prince George.

The Company announced in its October 14, 2020, news release that it had conducted a 9.7 kg surface sample which returned the following grades:

  • 62.1 grams per tonne Au
  • 320 grams per tonne Ag
  • 23.4% Pb, 12.4% Zn

In addition to surface sampling, chip sampling from the vein’s surface outcropping also returned high grade gold and silver assays (October 26, 2020 news release). 

Mr. Peter Espig, CEO of Nicola Mining Inc., commented, “We are very excited to commence production at our Dominion project, which highlights the strength of our mill’s permitting and location as a destination for small-project BC gold production.  Putting Dominion’s bulk sample into a position of extraction is the culmination of years of effort with accolades going out to our employees and partner, High Range Exploration.  We feel that BC is undergoing a renaissance as small high grade projects are receiving the support of First Nations, communities and ministries.”

Qualified Person

William Whitty, P. Geo., VP of Exploration for the Company, is the Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects has reviewed and approved the technical disclosure contained in this news release.

About Nicola Mining

Nicola Mining Inc. is a junior mining company listed on the Exchange and Frankfurt Exchange that maintains a 100% owned mill and tailings facility, located near Merritt, British Columbia. It has signed Mining and Milling Profit Share Agreements with high grade gold projects. Nicola’s fully permitted mill can process both gold and silver mill feed via gravity and flotation processes.

The Company owns 100% of the New Craigmont Project, a high-grade copper property, which covers an area of 10,913 hectares along the southern end of the Guichon Batholith and is adjacent to Highland Valley Copper, Canada’s largest copper mine. The Company also owns 100% of the Treasure Mountain Property, which includes 30 mineral claims and a mineral lease, spanning an area exceeding 2,200 hectares.

On behalf of the Board of Directors

“Peter Espig”  
Peter Espig
CEO & Director

For additional information

Contact: Peter Espig
Phone: (778) 385-1213
Email: info@nicolamining.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

[1] Bulk Sample:  An exploration and development activity conducted on a mineral claim to investigate the metallurgical properties of an ore body, to test extractive milling methods, mill equipment, and potential markets.

Release – GeoVax Urges Immediate Action on Pandemic Preparedness as Biodefense Gaps Expose Fragile Supply Chains

Posted on by aweinsoff@channelchek.com

Research News and Market Data on GOVX

With Mpox spreading globally, COVID-19 variants evading immunity, and bipartisan leaders demanding U.S.-based solutions, GeoVax calls for urgent investment in domestic manufacturing and vaccine diversification

Atlanta, GA – July 30, 2025 – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigenic vaccines and immunotherapies, today renewed its call for decisive U.S. action on pandemic preparedness and biodefense. With escalating outbreak risks, public health system strain, and growing bipartisan consensus for domestic solutions, GeoVax underscored the urgent need to modernize the nation’s countermeasure infrastructure and end foreign vaccine dependency.

“The warning signs are multiplying,” said David Dodd, Chairman and CEO of GeoVax. “We are facing the global expansion of virulent Mpox strains, immune-evasive COVID variants, and a national stockpile reliant on outdated, offshore platforms. Pandemic readiness must be built at home – with modern, American-made solutions and proactive government-industry leadership.”

GeoVax’s Domestic Platform for Emerging and Endemic Threats

GeoVax’s Modified Vaccinia Ankara (MVA)-based vaccine platform anchors two front-line candidates:

  • GEO-MVA for Mpox/smallpox, designed to protect against both Clade I and II Mpox strains.
  • GEO-CM04S1, a multi-antigen, next-generation COVID-19 vaccine targeting the 40 million U.S. immunocompromised through robust, durable, antibody and T-cell–driven immune protection.

The vaccine candidates are supported by Phase 2 clinical data (GEO-CM04S1) and favorable clinical development guidance from the European Medicines Agency (GEO-MVA) and current development plans include the implementation of an advanced MVA continuous avian cell line manufacturing process for U.S.-based, scalable production.

New Health Threats Demand Immediate Preparedness

  • Mpox: The World Health Organization maintains Mpox as a Public Health Emergency of International Concern. Clade I outbreaks have now spread to numerous continents, including sustained transmission in China and wastewater detection in the U.S. New data from the Democratic Republic of the Congo confirmed vertical transmission during pregnancy, raising fresh concerns for maternal and neonatal health.
  • COVID-19: The NB.1.8.1 (“Nimbus”) variant continues to gain dominance, prompting updated CDC guidance recommending boosters for vulnerable groups, including older adults and the immunocompromised. However, mRNA vaccine uptake remains low in these populations, reinforcing the need for broader, longer-lasting immunity options like GEO-CM04S1.

Alarmingly, the Strategic National Stockpile (SNS) remains overly dependent on a single foreign supplier for Mpox/smallpox MVA vaccine, which is reportedly unable to supply the current estimated global needs.  Most concerning, the U.S. government has had to continuously shift MVA vaccine from the SNS, which is primarily intended for biosecurity purposes, resulting in a vicious cycle of SNS replenishment, followed by further reduction of the SNS as Mpox outbreaks continue.

“The cost of delay is steep, and the status quo is unacceptable,” said Dodd. “The United States needs increased MVA vaccine competition – not complacency and dependency on a foreign, monopolistic supplier.”

Bipartisan Momentum and Federal Mandate for Action

Policymakers across the aisle are rallying behind a more secure biodefense posture:

  • At BIO 2025, Administration for Strategic Preparedness and Response (ASPR) Chief of Staff Mark O’Neill emphasized the need for onshoring, platform diversification, and public-private partnerships to strengthen domestic pandemic response capabilities.
  • In Congress, Democrats and Republicans alike are advancing legislation to reduce foreign dependency and prioritize U.S.-based manufacturing and procurement for pandemic countermeasures.

“GeoVax supports and welcomes this emerging consensus,” Dodd added. “We’re aligned with ASPR and BARDA priorities – and we’re ready to deliver. Swift, decisive government action is needed.”

Preparedness Requires Investment – Before the Next Crisis

More than 120 nations have signed the new WHO Pandemic Agreement, and the U.S. is scaling its biodefense footprint through mobile biocontainment units, genomic surveillance, and expanded diagnostics. Yet, without domestically produced, next-generation vaccines and a diversified stockpile, those efforts will fall short.

“We commend HHS, BARDA, ASPR, and congressional leaders for sounding the alarm,” concluded Dodd. “Now is the time to fund, procure, and manufacture domestically – before the next emergency hits.”

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax is also developing a vaccine targeting Mpox and smallpox and, based on recent EMA regulatory guidance, anticipates progressing directly to a Phase 3 clinical evaluation, omitting Phase 1 and Phase 2 trials. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

Forward-Looking Statements

This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control.

Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

info@geovax.com

678-384-7220

Investor Relations Contact:

geovax@precisionaq.com

212-698-8696

Media Contact:

Jessica Starman

media@geovax.com 

Release – Xcel Brands and TSC Product Lab Partner to Launch Products under the Trust. Respect. Love By Cesar Milan Brand in innovative pet electronic devices and small appliances category

Posted on by aweinsoff@channelchek.com

Research New and Market Data on XELB

July 30, 2025 at 8:00 AM EDT

PDF Version

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Xcel Brands (NASDAQ: XELB), a leading media and consumer products company known for building socially driven, live-commerce-focused brands, is proud to announce a strategic licensing partnership with TSC Product Lab, an innovation hub dedicated to premium lifestyle and wellness products, to launch new products for Trust. Respect. Love by Cesar Millan brand. This unique collaboration blends TSC Product Lab’s forward-thinking product development capabilities with Xcel’s expertise in omnichannel brand building, products and social commerce in the rapidly growing creator economy.

Together, Xcel and TSC Product Lab will produce a line of elevated pet products designed with purpose and functionality while keeping Cesar Millan’s philosophy at the forefront. The product line will include smart electronic devices and small appliances—all developed with pet wellbeing and human-animal harmony in mind.

“Nothing matters more these days than the health and wellness of our four legged best friends” said Rick Lapine, President of TSC Product Lab, “with that single focus we are innovating leading edge products that embody the spirit and guidance Cesar teaches, with affordable solutions for every family’s most loved companions”

With over 20 years of experience transforming the lives of dogs and their humans, Cesar Millan brings authenticity and purpose to the brand. His signature philosophy—Trust. Respect. Love—serves as the foundation for a product line built to strengthen bonds and provide practical, meaningful solutions for everyday pet ownership.

“This launch represents our continued commitment to creating lifestyle brands that resonate with modern consumers,” said Robert W. D’Loren, Chairman and CEO of Xcel Brands. “The pet space is evolving rapidly, and with TSC Product Lab’s innovation-first approach and Cesar Millan’s unmatched authenticity, we’re introducing a brand that blends education, design, and emotional connection.”

“I am very excited to add another partner to our ever-growing Trust. Respect. Love by Cesar Millan pack. Technology should bring us closer to our pets, not farther apart. This partnership is about creating smart solutions that help pet parents better understand , connect with and care for their dogs in a natural balanced way. Together, we’re shaping the future of pet products—one innovation at a time” -Cesar Millan

The brand will be available through select retailers, e-commerce platforms, and live shopping channels. This announcement further pushes Xcel’s commitment to redefining social shopping through innovative partnerships with authentic, visionary creators. For more information, visit www.xcelbrands.com

About Xcel Brands
Xcel Brands, Inc. (NASDAQ: XELB) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Xcel owns the Halston, Judith Ripka, and C. Wonder brands, as well as the co-branded collaboration brands TowerHill by Christie Brinkley, LB70 by Lloyd Boston, Trust. Respect. Love by Cesar Millan, GemmaMade by Gemma Stafford, and a brand in development with Coco Rocha and also holds noncontrolling interests or long-term license agreements in the Isaac Mizrahi brand, Orme Live and Jenny Martinez Live brands. Xcel also owns and manages the Longaberger brand through its controlling interest in Longaberger Licensing, LLC. Xcel is pioneering a true modern consumer products sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels to be everywhere its customers shop. The company’s brands have generated in excess of $5 billion in retail sales via livestreaming in interactive television and digital channels alone and consisting of over 20,000 hours of content production time in live-stream and social commerce. The brand portfolio reaches in excess of 43 million social media followers with broadcast reach into 200 million households. Headquartered in New York City, Xcel Brands is led by an executive team with significant live streaming, production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer products companies. For more information, visit www.xcelbrands.com.

About TSC Lab Products
The Sneaky Chef Product Lab (“TSC”) is a cost-effective product development and sourcing company specializing in innovative solutions for the home. The Company’s mission is to create products and brands for leading retailers. Since 2007, TSC has built a diverse portfolio of owned, private label and exclusively licensed brands and has partnered with such legacy names such as Martha Stewart, Sodastream, GreenPan and Calvin Klein. Its network of retail partners includes HSN, QVC, Walmart, Amazon and TJX Companies among others.

Led by Rick Lapine, an industry veteran with decades of experience, TSC is supported by a full-time team of passionate experts, bringing over 30 years of combined expertise in sourcing and production. This team has helped establish TSC as a trusted partner for efficient product development, manufacturing, and logistics, with the capability to execute projects rapidly and reliably.

About Cesar Millan 
Cesar Millan is a world-renowned dog behaviorist with over 25 years of experience transforming relationships between humans and their dogs. From his original hit TV series, the Dog Whisperer, to his most recent TV series Better Human, Better Dog, to his best-selling books and iconic workshops, Cesar has become a trusted guide for millions of dog lovers worldwide. With a social media following of over 21 million people and a legacy that spans two decades on television around the world, Cesar’s influence extends far and wide. Trusted by celebrities, world leaders, and first-time pet owners alike, Cesar is committed to helping you achieve lasting harmony with your dog. Cesar moves forward in his journey with purpose and you can follow this journey at www.cesarmillan.com.

For further information please contact:
Seth Burroughs
Xcel Brands
sburroughs@xcelbrands.com

Blanca Lassalle
Publicity Contact for Cesar Millan
blanca@creativelinkny.com

Primary Logo

Source: Xcel Brands, Inc

Release – Large Target Zone Confirmed at Aurania’s Awacha Porphyry Copper Target

Posted on by aweinsoff@channelchek.com

Research News and Market Data on AUIAF

July 30, 2025 7:00 AM EDT | Source: Aurania Resources Ltd.

Toronto, Ontario–(Newsfile Corp. – July 30, 2025) – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) (“Aurania” or the “Company”) announces that a large zone of hydrothermal alteration has been revealed following data review and interpretation from the Anaconda-style mapping program completed at the Company’s Awacha project in Ecuador in 2024. The Anaconda method is characterized by a systematic and detailed approach to recording geological data that has facilitated the discovery of several deposits, including the giant Alpala porphyry Cu-Au-Ag deposit in northern Ecuador and the Cortadera porphyry Cu-Au-Mo deposit cluster in northern Chile. Significantly, the zone of interest at the Awacha porphyry copper target area is spatially coincident with both a magnetic high anomaly and an area of elevated Mobile MagnetoTellurics (MobileMT) conductivity, warranting additional field work to refine drill hole locations for a future anticipated drill program.

Interpretation of the data was finalized in early June, and the Company engaged porphyry copper expert Dr. Steve Garwin (see press release dated June 27, 2025) to review the Anaconda-style mapping data and identify the most promising porphyry targets in the Awacha area. Dr. Garwin is credited as being instrumental in the discovery of several major ore deposits, including the Alpala porphyry copper-gold deposit at the Cascabel project in Ecuador. Dr Garwin has recommended evaluating the defined target through detailed 1:1,000- to 1:2,000-scale Anaconda-style mapping with the objective of establishing drill pad locations. He also advised extending field prospecting and soil sampling coverage to the west, over MobileMT anomalies 1 and 2 (see press release dated June 27, 2025).

Dr. Garwin confirmed that the Anaconda method has revealed a large zone (>6 km by 4 km) of hydrothermal alteration affecting Mesozoic hornblende-bearing intrusions hosted by Jurassic siliciclastic rocks (Santiago Formation). This alteration is characterized by an early-stage propylitic assemblage (chlorite + epidote), with localized zones of potassic (biotite) alteration, followed by a late-stage phyllic (quartz-sericite-pyrite), argillic (kaolinite-illite/smectite), and advanced argillic (dickite-pyrophyllite) alteration. A central argillic zone measuring approximately 2 km (north-south) by 1 km (east-west) is flanked by phyllic and localized advanced argillic zones (see Figure 1).

Rock-chip sampling has yielded up to 0.37% Cu, 0.20 g/t Au, 580 ppm As, 49 ppm Bi and 306 ppm Mo at the surface. Zones of elevated Cu:Zn ratios and Mo in soil and rock-chip define a 6km by 4km ring to the central argillic zone. Rock chips with chalcopyrite and elevated chalcopyrite:pyrite ratio define a ~ 2km diameter zone located to the southwest of the central argillic zone. Through-going and planar crystalline quartz veinlets, characterized by medial sutures of chalcopyrite-pyrite and seams of molybdenite are mapped in the vicinity of the chalcopyrite occurrences (see Figure 1). Both Cu and Mo are primary indicators of porphyry mineralization, with elevated Cu:Zn ratios and the sulphide-bearing veinlets suggesting proximity to the mineralized core.

Based on these observations, Dr. Garwin has delineated a 2,200 m x 1,200 m target zone, supported by a magnetic high anomaly and an area of elevated MobileMT conductivity (see Figures 2 and 3). Magnetic high anomalies can indicate zones of potassic alteration with abundant magnetite in the subsurface, which are closely associated with the core of mineralized porphyry systems. In proximity to the core, high conductivity anomalies can indicate the presence of electrically conductive sulphide minerals such as pyrite and the primary minerals of economic interest in porphyry copper deposits: chalcopyrite and bornite. Significantly, the subsurface magnetic and MobileMT highs are spatially coincident with high chalcopyrite/pyrite zones delineated in the surface mapping.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/2477/260603_2235c429f436e988_001.jpg

Figure 1: Main Anaconda method mapping results at the Awacha target area (high-priority target zone outlined in red) with select interpreted MobileMT anomalies (magenta outlines). Cp = chalcopyrite; Py = pyrite. 

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2477/260603_2235c429f436e988_001full.jpg

Cannot view this image? Visit: https://images.newsfilecorp.com/files/2477/260603_2235c429f436e988_002.jpg

Figure 2: Left image, MobileMT depth slice at 700 m above sea level showing the position of the Awacha target area (red outline) over the MobileMT anomaly 6 (red colour is high conductivity and blue colour is high resistivity). Right image, RTP magnetic airborne showing the position of the target area over the major magnetic anomaly.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2477/260603_2235c429f436e988_002full.jpg



Figure 3: East-west cross section of the MobileMT 2.5D inversion at the Awacha target area (red outline in Figure 2 above Anomaly 6), looking north. The top of Anomaly 6 is approximately 200m below the surface.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2477/260603_2235c429f436e988_003full.jpg

The Anaconda-style mapping was completed over a 17 km² area at the Awacha target. A total of more than 2,200 outcrops were studied and described by field geologists and subsequently compiled into a database.

Qualified Persons:

The geological information contained in this news release has been verified and approved by Aurania’s VP Exploration, Mr. Jean-Paul Pallier, MSc. Mr. Pallier is a designated EurGeol by the European Federation of Geologists and a Qualified Person as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects of the Canadian Securities Administrators.

About Aurania

Aurania is a mineral exploration company engaged in the identification, evaluation, acquisition and exploration of mineral property interests, with a focus on precious metals and copper in South America. Its flagship asset, The Lost Cities – Cutucu Project, is located in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador.

Information on Aurania and technical reports are available at www.aurania.com and www.sedarplus.ca, as well as on Facebook at https://www.facebook.com/auranialtd/, X (formerly Twitter) at https://x.com/AuraniaLtd , and LinkedIn at https://www.linkedin.com/company/aurania-resources-ltd-.

For further information, please contact:

Carolyn Muir
VP Corporate Development & Investor Relations
Aurania Resources Ltd.
(416) 367-3200
carolyn.muir@aurania.com		 

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information as such term is defined in applicable securities laws, which relate to future events or future performance and reflect management’s current expectations and assumptions. The forward-looking information includes Aurania’s objectives, goals or future plans, statements, exploration results, potential mineralization, the tonnage and grade of mineralization which has the potential for economic extraction and processing, the merits and effectiveness of known process and recovery methods, the corporation’s portfolio, treasury, management team and enhanced capital markets profile, the estimation of mineral resources, exploration, timing of the commencement of operations, the commencement of any drill program and estimates of market conditions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to Aurania, including the assumption that, there will be no material adverse change in metal prices, all necessary consents, licenses, permits and approvals will be obtained, including various local government licenses and the market. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. Risk factors that could cause actual results to differ materially from the results expressed or implied by the forward-looking information include, among other things: failure to identify mineral resources; failure to convert estimated mineral resources to reserves; the inability to complete a feasibility study which recommends a production decision; the preliminary nature of metallurgical test results; the inability to recover and process mineralization using known mining methods; the presence of deleterious mineralization or the inability to process mineralization in an environmentally acceptable manner; commodity prices, supply chain disruptions, restrictions on labour and workplace attendance and local and international travel; a failure to obtain or delays in obtaining the required regulatory licenses, permits, approvals and consents; an inability to access financing as needed; an inability to fund or extend the payment of Ecuador mineral concession fees which are due and payable and could result in the forfeiture of such mineral concessions; an inability to fund the administrative fees imposed by the Ecuadorian Control and Regulation Agency (ARCOM for its Spanish acronym) on the mining sector which could render the Company insolvent; a general economic downturn, a volatile stock price, labour strikes, political unrest, changes in the mining regulatory regime governing Aurania; a failure to comply with environmental regulations; a weakening of market and industry reliance on precious metals and base metals; and those risks set out in the Company’s public documents filed on SEDAR+. Aurania cautions the reader that the above list of risk factors is not exhaustive. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

info

SOURCE: Aurania Resources Ltd.

10-Year Treasury Yield Climbs After Strong GDP Data as Fed Decision Looms

Posted on by slightbourne@noblecapitalmarkets.com

U.S. Treasury yields rose on Wednesday as stronger-than-expected economic growth reinforced expectations that the Federal Reserve will maintain its current interest rate stance, even amid growing political pressure and global market sensitivities.

The benchmark 10-year Treasury yield climbed to 4.368%, reflecting rising investor confidence in the strength of the U.S. economy. The 2-year and 30-year yields also increased, closing at 3.904% and 4.904%, respectively. The moves followed a sharp rebound in second-quarter GDP, which showed the economy growing at an annualized rate of 3% — well above forecasts and reversing a 0.5% decline from the first quarter.

This robust data supports the case for keeping rates steady, at least in the near term, as the Federal Reserve continues to weigh inflation trends, labor market resilience, and long-term growth prospects. The Fed is widely expected to hold its benchmark interest rate between 4.25% and 4.5% during today’s announcement, but all eyes are on Chair Jerome Powell’s comments for insight into what comes next.

Adding complexity to the current environment is an ongoing effort by former President Donald Trump to pressure the Fed into lowering interest rates. Trump has criticized Powell’s leadership and floated the idea of replacing him in a potential second term. Despite this political noise, bond markets appear to be looking past the rhetoric, focusing instead on macroeconomic fundamentals. The continued rise in the 10-year yield suggests investors believe any leadership changes at the Fed would have little immediate impact on market direction.

Moreover, foreign holders of U.S. Treasuries could react to political instability or aggressive fiscal policy by offloading U.S. debt. This would push yields even higher, particularly if confidence in long-term economic or monetary policy erodes. The bond market’s sensitivity to global sentiment means that political pressure campaigns are unlikely to meaningfully influence interest rates without broader structural changes.

Adding further pressure is the threat of new tariffs, a cornerstone of Trump’s proposed economic agenda. Tariffs on imported goods would likely raise costs across the board, fueling inflation and reducing purchasing power domestically. As the U.S. imports many essential goods, any significant tariffs would shift costs onto consumers and businesses. This could complicate the Fed’s effort to keep core inflation within its 2% to 2.5% target range and delay any potential interest rate cuts.

For now, financial markets are signaling confidence in the Fed’s ability to manage the current environment, even if political rhetoric intensifies. Investors appear to be aligning their expectations with strong economic indicators and current inflation data rather than political speculation.

As the Federal Reserve’s decision looms, the upward movement in Treasury yields reflects not just optimism about U.S. growth, but also a more complex web of factors — from global capital flows and inflation expectations to political interference and international trade risks. The road ahead for monetary policy remains uncertain, but the market’s message is clear: economic fundamentals, not politics, will drive yields.

Graham (GHM) – $25.5 Million Follow-on Order

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, July 30, 2025

Graham Corporation designs, manufactures and sells critical equipment for the energy, defense and chemical/petrochemical industries. The Company designs and manufactures custom-engineered ejectors, vacuum pumping systems, surface condensers and vacuum systems. It is a nuclear code accredited fabrication and specialty machining company. It supplies components used inside reactor vessels and outside containment vessels of nuclear power facilities. Its equipment is found in applications, such as metal refining, pulp and paper processing, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning. For the defense industry, its equipment is used in nuclear propulsion power systems for the United States Navy. The Company’s products are used in a range of industrial process applications in energy markets, including petroleum refining, defense, chemical and petrochemical processing, power generation/alternative energy and other.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Follow-on Order. Yesterday, Graham Corporation announced the Company was awarded a follow-on order to produce critical hardware for the MK48 Mod 7 Heavyweight torpedo program. This was a sole sourced award. Graham typically receives an annual order for this program once funding is approved for the current year’s supply.

MK48 Program. The follow-on order is valued at approximately $25.5 million. Graham manufactures and tests the alternators and regulators for the MK48 Mod 7 Heavyweight torpedo through its Barber-Nichols subsidiary. We believe there are two more option years remaining under the current program in which 50-120 MK 48s are produced annually.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Alliance Resource Partners (ARLP) – Solid Second Quarter Performance; Cash Flow Profile Remains Attractive

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, July 30, 2025

ARLP is a diversified natural resource company that generates operating and royalty income from coal produced by its mining complexes and royalty income from mineral interests it owns in strategic oil & gas producing regions in the United States, primarily the Permian, Anadarko and Williston basins. ARLP currently produces coal from seven mining complexes its subsidiaries operate in Illinois, Indiana, Kentucky, Maryland and West Virginia. ARLP also operates a coal loading terminal on the Ohio River at Mount Vernon, Indiana. ARLP markets its coal production to major domestic and international utilities and industrial users and is currently the second largest coal producer in the eastern United States. In addition, ARLP is positioning itself as an energy provider for the future by leveraging its core technology and operating competencies to make strategic investments in the fast growing energy and infrastructure transition.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Second quarter financial results. Alliance reported second quarter adjusted EBITDA and earnings per unit (EPU) of $161.9 million and $0.46, respectively, compared to $181.4 million and $0.77 during the prior year period. We had projected EBITDA and EPU of $159.8 million and $0.57. Reported earnings per unit include a $25 million non-cash impairment charge. Total revenue amounted to $547.5 million compared to $593.4 million during the prior year period and our $577.4 million estimate. The variance compared to our revenue estimate was largely due to lower coal sales.

Outlook for the remainder of 2025 and 2026. Management increased the top end of 2025 coal tonnage sales guidance, kept overall coal sales price expectations intact, and lowered guidance for segment adjusted EBITDA expense per ton sold. Notably, oil and gas royalty volume expectations were increased, while segment adjusted EBITDA expense as a percentage of oil and gas royalty revenues was decreased to 14% from 15%. While management expects the average coal sales price per ton to trend lower in 2026 due to higher-priced contracts rolling off, longwall moves in 2025 and actions to improve productivity and cost effectiveness are expected to offset the impact of lower prices.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

FAT Brands (FAT) – Charges Dropped

Posted on by slightbourne@noblecapitalmarkets.com


Wednesday, July 30, 2025

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and develops fast casual, quick-service, casual dining, and polished casual dining concepts around the world. The Company currently owns 17 restaurant brands: Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Fazoli’s, Twin Peaks, Great American Cookies, Hot Dog on a Stick, Buffalo’s Cafe & Express, Hurricane Grill & Wings, Pretzelmaker, Elevation Burger, Native Grill & Wings, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises and owns over 2,300 units worldwide. For more information on FAT Brands, please visit www.fatbrands.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Charges Dropped. Last night, FAT Brands announced that the United States Attorney for the Central District of California has filed a motion to dismiss all charges against Andrew Wiederhorn, FAT Brands, Rebecca Hershinger, and William Amon. This is a major development in our view, not only removing significant ongoing related legal fees for FAT Brands, but also any lingering reputational risk investors may have had related to the action. It remains to be seen if last night’s action will result in a similar favorable resolution to the SEC civil action.

Background. The original charges from the U.S. District Attorney were filed back in May 2024, while, simultaneously, the SEC filed a civil complaint accusing Mr. Wiederhorn of using FAT cash to fund his lifestyle, while falsely telling the Company’s auditors, Board of Directors, and investors that neither he nor his family members had any direct or indirect material interest in the FAT cash used by Mr. Wiederhorn for personal expenditures.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CyberArk Shares Soar as Palo Alto Networks Eyes $20 Billion+ Acquisition

Posted on by slightbourne@noblecapitalmarkets.com

In a potential seismic shift in the cybersecurity landscape, shares of CyberArk soared by as much as 18% Tuesday following reports that Palo Alto Networks is in advanced talks to acquire the identity security firm in a deal exceeding $20 billion.

The reported deal, first published by The Wall Street Journal, would mark Palo Alto Networks’ largest acquisition to date, far surpassing its recent spree of cybersecurity buys and signaling a bold bet on the future of identity and cloud security. With a current market cap hovering around $132 billion, Palo Alto has emerged as the dominant force in the cybersecurity space, and a tie-up with CyberArk would only cement that leadership.

CEO Nikesh Arora, who took the helm at Palo Alto in 2018, has aggressively expanded the company’s portfolio in recent years, recently closing its purchase of Protect AI and acquiring Talon Cyber Security, Dig Security, and Zycada Networks in 2023. But a CyberArk deal would be in a league of its own — both in terms of size and strategic value.

CyberArk, based in Israel, specializes in identity management solutions — helping enterprises secure login credentials, privileged access, and sensitive systems. Its technologies are especially relevant in a business environment increasingly shaped by AI acceleration, cloud-first infrastructure, and a rising tide of ransomware threats. The company’s growth has reflected this demand: CyberArk’s first-quarter revenue jumped 43% year-over-year to $318 million, delivering $11.5 million in net income. Its stock has now climbed 29% in 2025, building on a 52% gain in 2024, and recently hit a record high.

Competition in the identity security space remains fierce, with Microsoft, Okta, IBM’s HashiCorp, and SailPoint all vying for enterprise customers. But CyberArk’s consistent performance and deep enterprise integration have made it a standout — and an attractive acquisition target.

As news of the potential deal broke, Palo Alto’s stock dipped 3.5%, likely due to investor concerns over the price tag and dilution. Still, the company’s shares are up nearly 9% year-to-date, reflecting continued confidence in its growth trajectory.

The possible merger comes amid a flurry of mega-deals in the cybersecurity sector. In March, Google announced its largest acquisition ever — a $32 billion purchase of cloud security firm Wiz. Similarly, Cisco shook the market in 2023 by acquiring Splunk for $28 billion, marking its biggest bet on data and threat intelligence tools.

While neither Palo Alto Networks nor CyberArk has officially commented on the acquisition rumors, industry observers suggest that the deal, if finalized, could redefine the competitive map for identity and cloud security in a rapidly evolving threat landscape.

Hiring Hits 7-Month Low as Fed Eyes Soft Landing

Posted on by slightbourne@noblecapitalmarkets.com
Key Points:
– Job openings and hiring rates declined in June, pointing to a cooling labor market.
– Slower labor momentum may support interest rate cuts, benefiting small-cap stocks.
– Wage and recruitment pressure may ease for lean growth-stage companies.

U.S. job openings and hiring took a step back in June, signaling a potential shift in the labor market that middle-market investors should watch closely — not fear. According to the Bureau of Labor Statistics, job openings slid to 7.44 million, while hiring dipped to 5.2 million, the lowest level seen since November 2024.

While the headlines suggest cooling momentum, the broader story may hold more nuanced opportunities, especially for investors focused on small and micro-cap companies. A slower labor market, in combination with steady inflation data, could strengthen the case for the Federal Reserve to hold — or even cut — interest rates in the coming months. That shift would support capital access and investor appetite for growth-stage businesses that have been squeezed by tight monetary policy.

Though hiring dipped, layoffs remain notably low, and the quits rate — a proxy for worker confidence — held steady at 2%. Economists are describing this as a market in “stasis,” but for long-term investors, the pause could be a prelude to renewed acceleration.

For small-cap companies, especially those in labor-sensitive sectors like retail, logistics, and light manufacturing, a cooling hiring pace may relieve wage pressure and improve margins. It also puts less strain on recruitment, potentially helping leaner firms maintain productivity without costly hiring sprees.

Meanwhile, private sector ADP data revealed a loss of 33,000 jobs in June — the first negative reading since March 2023 — and consumer confidence continues to weaken. Yet, this cooling sentiment could signal that wage inflation, a concern for the Fed, is abating. Should that trend continue, it strengthens the case for interest rate cuts by year-end — a move that historically benefits risk assets and small-cap equities more than their large-cap peers.

This week’s data will culminate in Friday’s July jobs report, which economists expect to show 101,000 jobs added and a rise in unemployment to 4.2%. If confirmed, it could validate investor bets on a looser monetary stance and provide a tailwind for undervalued companies that have struggled under high-rate conditions.

For middle-market investors, this is a moment to dig deeper into companies with strong fundamentals but weakened valuations. Lower rates could reignite M&A activity and growth funding in the lower end of the public markets. And while the broader labor market narrative may appear sluggish, it’s precisely this cooling that could set the stage for a more accommodative environment in the quarters ahead.

Release – Perfect Corp. Reports Unaudited Financial Results for the Three Months and the Six Months Ended June 30, 2025

Posted on by aweinsoff@channelchek.com

Research News and Market Data on PERF

July 29, 2025

    NEW YORK–(BUSINESS WIRE)– Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty and fashion industries, today announced its unaudited financial results for the three months ended June 30, 2025 and the six months ended June 30, 2025. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty and fashion industries, today announced its unaudited financial results for the three months ended June 30, 2025 and the six months ended June 30, 2025.

    Financial Results for the Three Months Ended June 30, 2025

    Revenue

    Total revenue was $16.3 million for the three months ended June 30, 2025, compared to $13.9 million in the same period of 2024, an increase of 17.6%. The increase was primarily due to strong growth momentum in the revenue of mobile app and web services subscriptions.

    • AI- and AR- cloud solutions and subscription revenue was $14.9 million for the three months ended June 30, 2025, compared to $12.9 million in the same period of 2024, an increase of 15.6%. The increase was driven by the continued revenue growth of YouCam mobile app and web services subscriptions, the growing popularity among consumers of Generative AI technologies and AI editing features for photos and videos, and the stable demand for the Company’s online virtual product try-on solutions from brand customers.
    • Licensing revenue was $0.9 million for the three months ended June 30, 2025, compared to $0.7 million in the same period of 2024, an increase of 36.5%.

    Gross Profit

    Gross profit was $12.3 million for the three months ended June 30, 2025, compared with $11.0 million in the same period of 2024, an increase of 11.6%. Gross margin was 75.3% for the three months ended June 30, 2025, slightly down from 79.3% in the same period of 2024. The decrease in gross margin was primarily due to the increase in third-party payment processing fees paid to digital distribution partners, such as Google and Apple, driven by the steady growth in our YouCam mobile app subscription revenue. In addition, the increases in AI server computing cost, resulting from the growing demand for premium features powered by generative AI services, also contributed to the decrease in gross margin

    Total Operating Expenses

    Total operating expenses were $13.8 million for the three months ended June 30, 2025, compared with $12.4 million in the same period of 2024, an increase of 10.8%. The increase was primarily due to increases in research and development and sales and marketing expenses, which were partially offset by a decrease in general and administrative expenses in the second quarter of 2025.

    • Sales and marketing expenses were $7.8 million for the three months ended June 30, 2025, compared to $7.0 million during the same period of 2024, an increase of 11.3%. This increase was primarily due to an increase in marketing events and advertising expenses related to our mobile apps and web services subscription.
    • Research and development expenses were $4.0 million for the three months ended June 30, 2025, compared to $3.0 million during the same period of 2024, an increase of 35.5%. The increase was caused by two main factors: (i) the foreign exchange impact caused by the depreciation of the U.S. dollar against New Taiwan dollar elevated personnel costs for our Taiwan-based development team, and (ii) the increase in research and development headcount and related compensation expenses following the acquisition of Wannaby Inc. (“Wannaby”).
    • General and administrative expenses were $2.0 million for the three months ended June 30, 2025, compared to $2.4 million during the same period of 2024, a decrease of 18.0%. The decrease was primarily due to reduced corporate insurance premium and external professional service fees.

    Net Income

    Net income was $0.2 million for the three months ended June 30, 2025, compared to $0.8 million during the same period of 2024, a decrease of 72.9%. The decrease in net income was primarily due to (i) higher third-party payment processing fees, (ii) higher Taiwan personnel costs due to foreign exchange impact by a weaker U.S. dollar, (iii) increases in operating expenses after the acquisition of Wannaby, and (iv) lowered interest income due to decreases in interest rates on the Company’s cash reserve.

    Adjusted Net Income (Non-IFRS)1

    Adjusted net income was $0.4 million for the three months ended June 30, 2025, compared to $1.3 million in the same period of 2024, a decrease of 68.3%.

    Operating Cash Flow

    Operating cash flow was $3.7 million in the three months ended June 30, 2025, compared to $2.0 million in the same period of 2024, an increase of 83.4%.

    Financial Results for the Six Months Ended June 30, 2025

    Revenue

    Total revenue was $32.4 million for the six months ended June 30, 2025, compared to $28.2 million in the same period of 2024, an increase of 14.8%.

    • AI- and AR- cloud solutions and subscription revenue was $29.0 million for the six months ended June 30, 2025, compared to $25.3 million in the same period of 2024, an increase of 14.5%. The increase was driven by the continued revenue growth of YouCam mobile app and web services subscriptions.
    • Licensing revenue was $2.6 million for the six months ended June 30, 2025, compared to $2.3 million in the same period of 2024, an increase of 12.1%.

    Gross Profit

    Gross profit was $24.8 million for the six months ended June 30, 2025, compared with $22.2 million in the same period of 2024, an increase of 11.5%. Gross margin was 76.6% for the six months ended June 30, 2025, slightly down from 78.8% in the same period of 2024.

    Total Operating Expenses

    Total operating expenses were $26.4 million for the six months ended June 30, 2025, compared with $24.8 million in the same period of 2024, an increase of 6.4%. The increase was primarily due to increases in research and development and sales and marketing expenses, which were partially offset by a decrease in general and administrative expenses during the period.

    • Sales and marketing expenses were $15.2 million for the six months ended June 30, 2025, compared to $14.2 million during the same period of 2024, an increase of 7.0%.
    • Research and development expenses were $7.6 million for the six months ended June 30, 2025, compared to $6.0 million during the same period of 2024, an increase of 26.4%.
    • General and administrative expenses were $3.7 million for the six months ended June 30, 2025, compared to $4.6 million during the same period of 2024, a decrease of 19.7%.

    Net Income

    Net income was $2.5 million for the six months ended June 30, 2025, compared to $1.4 million during the same period of 2024, an increase of 79.3%.

    Adjusted Net Income (Non-IFRS)1

    Adjusted net income was $2.4 million for the six months ended June 30, 2025, compared to $2.8 million in the same period of 2024, a decrease of 12.9%.

    Operating Cash Flow

    Operating cash flow was $8.0 million in the six months ended June 30, 2025, compared to $5.5 million in the same period of 2024, an increase of 44.7%. The Company continues to invest in growth while maintaining a healthy cash flow to support business operations underscoring the Company’s operational health and sustainability.

    Capital Resource

    As of June 30, 2025, the Company’s cash and cash equivalents remained stable at $125.3 million (or $167.8 million when including 6-month time deposits of $36.3 million and money market funds of $6.2 million, which are classified as current financial assets at amortized cost and current financial assets at fair value through profit or loss under IFRS, respectively), compared to $127.1 million (or $165.9 million when including time deposits and money market funds) as of December 31, 2024.

    Key Business Metrics

    • The number of active subscriber for the Company’s YouCam mobile beauty app and web services was 960,000 as of June 30, 2025, compared to over 919,000 as of June 30, 2024, an increase of 4.4%.
    • As of June 30, 2025, the Company’s cumulative customer base included 818 brand clients, with over 914,000 digital stock keeping units (“SKUs”) for makeup, haircare, skincare, shoes, bags, eyewear, watches and jewelry products, compared to 686 brand clients and over 774,000 digital SKUs as of June 30, 2024. The number of Key Customers 2 of the Company as of June 30, 2025 was 139 compared to 151 as of June 30, 2024. Half of the net decrease in Key Customer count was due to customers being downgraded as a result of lower spending during the period, while the other half was driven by customer churn amid ongoing macroeconomic challenges in the beauty and luxury sectors.

    CEO Remarks and Business Outlook for 2025

    Ms. Alice H. Chang, the Founder, Chairwoman, and Chief Executive Officer of Perfect commented, “Our mobile app and web subscription business continues to demonstrate strong momentum, now growing significantly faster than our enterprise segment. B2C subscriptions have become the primary driver of our overall revenue growth, fueled by sustained demand for our photo- and video-based generative AI features. While the enterprise business remains strategic, many clients are approaching new AI initiatives with caution amid broader macroeconomic uncertainty. As such, we maintain a prudent near-term outlook for B2B.

    2025 is shaping up to be a transformative year for Perfect Corp. Artificial intelligence is no longer a supporting capability. It is the foundation of both our product roadmap and operational strategy. Our expanded investment in generative AI is delivering tangible results. The YouCam product family now integrates cutting-edge features such as text-to-video, photo-to-video, and AI-powered image and video enhancements, making it an essential tool for mobile-first creators. These innovations are enabling users to produce high-quality content in minutes, accelerating engagement across our platforms.

    Internally, AI is driving operational excellence. From workflow automation and advanced analytics to virtual assistants and enhanced forecasting, AI is helping us scale more efficiently and deliver greater value. These gains benefit both our global subscriber base and the 800+ beauty and fashion brands that rely on Perfect Corp. to power their digital experiences.

    Looking ahead, we remain fully committed to advancing our generative AI capabilities. We are expanding our R&D pipeline and scaling our infrastructure to anticipate and meet evolving user demands. Our strategic focus is clear: deliver breakthrough user experiences that are faster, more personalized, and more engaging.

    For the second half of 2025, we see three key growth catalysts:

    1. Continued momentum in our GenAI-powered B2C apps and web subscriptions
    2. A stable and resilient enterprise pipeline
    3. Operational efficiency driven by AI-enabled processes

    With innovation, accessibility, and execution at the core of our strategy, we are confident in our ability to create sustained value for users, brand partners, employees, and shareholders.

    Based on the revenue growth momentum in both YouCam mobile apps and web service subscriptions and the sustained demand for enterprise SaaS solution, the Company reiterates its full year 2025 revenue guidance of 13.0% to 14.5% year-over-year, compared to 2024. This outlook reflects our latest view of market dynamics and internal performance, and is subject to adjustment should conditions change.”

    About Perfect Corp.

    Founded in 2015, Perfect Corp. is a leading AI company offering self-developed AI- and AR- powered solutions dedicated to transforming the world with digital tech innovations that make your virtual world beautiful. On Perfect’s direct consumer business side, Perfect operates a family of YouCam consumer apps and web-editing services for photo, video and camera users, centered on unleashing creativity with AI-driven features for creation, beautification and enhancement. On Perfect’s enterprise business side, Perfect empowers major beauty, skincare, fashion, jewelry, and watch brands and retailers by supplying them with omnichannel shopping experiences through AR product try-ons and AI-powered skin diagnostics. With cutting-edge technologies such as Generative AI, real-time facial and hand 3D AR rendering and cloud solutions, Perfect enables personalized, enjoyable, and engaging shopping journey and helps brands elevate customer engagement, increase conversion rates, and propel sales growth. Throughout this journey, Perfect maintains its unwavering commitment to environmental sustainability and fulfilling social responsibilities. For more information, visit https://ir.perfectcorp.com/.

    Forward-Looking Statements

    This communication contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on beliefs and assumptions and on information currently available to Perfect. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. These statements are based on Perfect’s reasonable expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Perfect’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Perfect to predict these events or how they may affect Perfect. In addition, risks and uncertainties are described in Perfect’s filings with the Securities and Exchange Commission. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Perfect cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that Perfect presently does not know or that Perfect currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by Perfect, its directors, officers or employees or any other person that Perfect will achieve its objectives and plans in any specified time frame, or at all. Except as required by applicable law, Perfect does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of Perfect as of any date subsequent to the date of this communication.

    Use of Non-IFRS Financial Measures

    This press release and accompanying tables contain certain non-IFRS financial measures, including adjusted net income, as supplemental metrics in reviewing and assessing Perfect’s operating performance and formulating its business plan. Perfect defined these non-IFRS financial measures as follows:

    Adjusted net income (loss) is defined as net income (loss) excluding one-off transaction costs3, non-cash equity-based compensation, and non-cash valuation (gain)/loss of financial liabilities. For a reconciliation of adjusted net income (loss) to net income (loss), see the reconciliation table included elsewhere in this press release.

    Non-IFRS financial measures are not defined under IFRS and are not presented in accordance with IFRS. Non-IFRS financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-IFRS financial measures. In addition, the non-IFRS financial measures Perfect uses may differ from the non-IFRS measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-IFRS financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with IFRS. The items excluded from our adjusted net income are not driven by core results of operations and render comparison of IFRS financial measures with prior periods less meaningful. We believe adjusted net income provides useful information to investors and others in understanding and evaluating our results of operations, as well as providing a useful measure for period-to-period comparisons of our business performance. Moreover, such non-IFRS measures are used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic planning and annual budgeting.

    View full release here.

    Investor Relations Contact
    Investor Relations, Perfect Corp.
    Email: Investor_Relations@PerfectCorp.com